Lymph  	Lymph  	 FW	B-NP
node-positive  	node-positive  	 FW	I-NP
stage  	stage  	 FW	I-NP
IIIC  	IIIC  	 FW	I-NP
ovarian  	ovarian  	 FW	I-NP
cancer 	cancer 	 NN	I-NP
:  	:  	 :	O
a  	a  	 DT	O
separate  	separate  	 JJ	O
entity 	entity 	 NN	O
?  	?  	 .	O
Ovarian  	Ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
spreads  	spreads  	 NNS	I-NP
via  	via  	 IN	O
the  	the  	 DT	O
retroperitoneal  	retroperitoneal  	 JJ	B-NP
lymphatics 	lymphatics 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
these  	these  	 DT	O
lymph  	lymph  	 JJ	O
nodes  	nodes  	 NNS	O
frequently  	frequently  	 RB	O
contain  	contain  	 VB	O
metastasis 	metastasis 	 NNS	B-NP
.  	.  	 .	O
A  	A  	 DT	O
subset  	subset  	 NN	B-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
whose  	whose  	 WP$	O
disease  	disease  	 NN	O
was  	was  	 VBD	O
classified  	classified  	 VBN	O
as  	as  	 IN	O
stage  	stage  	 NN	B-NP
IIIC  	IIIC  	 NNP	I-NP
has  	has  	 VBZ	O
retroperitoneal  	retroperitoneal  	 JJ	B-NP
lymph  	lymph  	 JJ	I-NP
node  	node  	 JJ	I-NP
metastases  	metastases  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
pelvic  	pelvic  	 JJ	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
para-aortic  	para-aortic  	 JJ	B-NP
lymph  	lymph  	 JJ	I-NP
nodes  	nodes  	 NN	I-NP
without  	without  	 IN	O
intraperitoneal  	intraperitoneal  	 JJ	B-NP
carcinomatosis  	carcinomatosis  	 NN	I-NP
and  	and  	 CC	O
was  	was  	 VBD	O
upstaged  	upstaged  	 VBN	O
from  	from  	 IN	O
stage  	stage  	 NN	O
I  	I  	 PRP	O
to  	to  	 TO	O
IIIB  	IIIB  	 NNP	B-NP
diseases  	diseases  	 NNS	I-NP
based  	based  	 VBN	O
on  	on  	 IN	O
these  	these  	 DT	O
findings 	findings 	 NNS	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
undergoing  	undergoing  	 VBG	O
cytoreductive  	cytoreductive  	 JJ	B-NP
surgery  	surgery  	 NN	I-NP
for  	for  	 IN	I-NP
advanced-stage  	advanced-stage  	 FW	I-NP
ovarian  	ovarian  	 FW	I-NP
cancer  	cancer  	 FW	I-NP
undergo  	undergo  	 FW	O
concomitant  	concomitant  	 FW	B-NP
retroperitoneal  	retroperitoneal  	 FW	I-NP
lymphadenectomy  	lymphadenectomy  	 FW	I-NP
in  	in  	 IN	O
an  	an  	 DT	O
effort  	effort  	 NN	O
to  	to  	 TO	O
improve  	improve  	 VB	O
their  	their  	 PRP$	O
survival 	survival 	 NN	O
.  	.  	 .	O
Stratification  	Stratification  	 NNP	B-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
stage  	stage  	 NN	B-NP
IIIC  	IIIC  	 NNP	I-NP
ovarian  	ovarian  	 JJ	I-NP
cancer  	cancer  	 NN	I-NP
by  	by  	 IN	O
lymph  	lymph  	 JJ	B-NP
node  	node  	 JJ	I-NP
status  	status  	 NN	I-NP
and  	and  	 CC	O
presence  	presence  	 NN	O
and  	and  	 CC	O
extent  	extent  	 NN	O
of  	of  	 IN	O
metastatic  	metastatic  	 JJ	B-NP
disease  	disease  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
peritoneal  	peritoneal  	 JJ	B-NP
cavity  	cavity  	 NN	I-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
performed 	performed 	 VBN	O
.  	.  	 .	O
Studies  	Studies  	 NNS	O
have  	have  	 VBP	O
determined  	determined  	 VBN	O
the  	the  	 DT	O
impact  	impact  	 NN	O
on  	on  	 IN	O
disease-free  	disease-free  	 JJ	B-NP
and  	and  	 CC	O
overall  	overall  	 JJ	O
survivals  	survivals  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
resection  	resection  	 NN	B-NP
of  	of  	 IN	I-NP
retroperitoneal  	retroperitoneal  	 JJ	I-NP
lymph  	lymph  	 JJ	I-NP
nodes  	nodes  	 NN	I-NP
as  	as  	 IN	O
part  	part  	 NN	O
of  	of  	 IN	O
primary  	primary  	 JJ	O
and  	and  	 CC	O
secondary  	secondary  	 JJ	B-NP
cytoreductive  	cytoreductive  	 JJ	I-NP
operations 	operations 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
overall  	overall  	 JJ	O
survival  	survival  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
stage  	stage  	 NN	B-NP
IIIC  	IIIC  	 NNP	I-NP
ovarian  	ovarian  	 JJ	I-NP
cancer  	cancer  	 NN	I-NP
based  	based  	 VBN	O
on  	on  	 IN	O
retroperitoneal  	retroperitoneal  	 FW	B-NP
lymph  	lymph  	 FW	I-NP
node  	node  	 FW	I-NP
metastasis  	metastasis  	 FW	I-NP
without  	without  	 FW	O
peritoneal  	peritoneal  	 FW	B-NP
carcinomatosis  	carcinomatosis  	 FW	I-NP
is  	is  	 VBZ	O
58 	58 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
84 	84 	 CD	O
%  	%  	 NN	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
18 	18 	 CD	O
%  	%  	 NN	O
to  	to  	 TO	O
36 	36 	 CD	O
%  	%  	 NN	O
for  	for  	 IN	O
those  	those  	 DT	O
with  	with  	 IN	O
macroscopic  	macroscopic  	 JJ	B-NP
peritoneal  	peritoneal  	 JJ	I-NP
carcinomatosis 	carcinomatosis 	 NN	I-NP
.  	.  	 .	O
Although  	Although  	 IN	O
the  	the  	 DT	O
performance  	performance  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
pelvic  	pelvic  	 JJ	O
and  	and  	 CC	O
para-aortic  	para-aortic  	 JJ	B-NP
lymphadenectomy  	lymphadenectomy  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
stage  	stage  	 NN	B-NP
IIIC  	IIIC  	 NN	I-NP
to  	to  	 TO	O
IV  	IV  	 NNP	O
diseases  	diseases  	 NNS	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
reported  	reported  	 VBN	O
to  	to  	 TO	O
prolong  	prolong  	 VB	O
survival 	survival 	 NN	O
,  	,  	 ,	O
an  	an  	 DT	O
international  	international  	 JJ	O
randomized  	randomized  	 JJ	B-NP
study  	study  	 NN	I-NP
did  	did  	 VBD	O
not  	not  	 RB	O
confirm  	confirm  	 VB	O
this  	this  	 DT	O
finding 	finding 	 NN	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
who  	who  	 WP	O
undergo  	undergo  	 VBP	O
secondary  	secondary  	 JJ	B-NP
resection  	resection  	 NN	I-NP
of  	of  	 IN	O
isolated  	isolated  	 FW	O
recurrent  	recurrent  	 FW	O
lymph  	lymph  	 FW	B-NP
node  	node  	 FW	I-NP
metastasis  	metastasis  	 FW	I-NP
have  	have  	 VBP	O
a  	a  	 DT	O
better  	better  	 JJR	O
survival  	survival  	 NN	O
than  	than  	 IN	O
those  	those  	 DT	O
with  	with  	 IN	O
more  	more  	 RBR	O
extensive  	extensive  	 JJ	B-NP
recurrent  	recurrent  	 JJ	I-NP
disease 	disease 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
data  	data  	 NNS	O
support  	support  	 VBP	O
the  	the  	 DT	O
stratification  	stratification  	 NN	B-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
stage  	stage  	 NN	B-NP
IIIC  	IIIC  	 NNP	I-NP
ovarian  	ovarian  	 JJ	I-NP
cancer  	cancer  	 NN	I-NP
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
finding  	finding  	 NN	O
of  	of  	 IN	O
metastasis  	metastasis  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
retroperitoneal  	retroperitoneal  	 JJ	B-NP
lymph  	lymph  	 JJ	I-NP
nodes  	nodes  	 NN	I-NP
without  	without  	 IN	O
peritoneal  	peritoneal  	 JJ	B-NP
carcinomatosis  	carcinomatosis  	 NN	I-NP
versus  	versus  	 IN	O
those  	those  	 DT	O
who  	who  	 WP	O
have  	have  	 VBP	O
peritoneal  	peritoneal  	 JJ	B-NP
carcinomatosis 	carcinomatosis 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
International  	International  	 NNP	O
Federation  	Federation  	 NNP	O
of  	of  	 IN	O
Gynecology  	Gynecology  	 NNP	B-NP
and  	and  	 CC	O
Obstetrics  	Obstetrics  	 NNP	B-NP
Committee  	Committee  	 NNP	I-NP
should  	should  	 MD	O
consider  	consider  	 VB	O
modifying  	modifying  	 VBN	O
the  	the  	 DT	O
ovarian  	ovarian  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
staging  	staging  	 NN	I-NP
system  	system  	 NN	I-NP
by  	by  	 IN	O
further  	further  	 JJ	O
stratifying  	stratifying  	 JJ	O
stage  	stage  	 NN	O
III  	III  	 NNP	O
disease 	disease 	 NN	O
.  	.  	 .	O
Although  	Although  	 IN	O
systematic  	systematic  	 JJ	B-NP
lymphadenectomy  	lymphadenectomy  	 NN	I-NP
during  	during  	 IN	O
primary  	primary  	 JJ	B-NP
cytoreductive  	cytoreductive  	 JJ	I-NP
surgery  	surgery  	 NN	I-NP
does  	does  	 VBZ	O
not  	not  	 RB	O
appear  	appear  	 VB	O
to  	to  	 TO	O
improve  	improve  	 VB	O
overall  	overall  	 JJ	O
survival 	survival 	 NN	O
,  	,  	 ,	O
resection  	resection  	 VBG	O
of  	of  	 IN	O
isolated  	isolated  	 FW	B-NP
lymph  	lymph  	 FW	I-NP
node  	node  	 FW	I-NP
metastasis  	metastasis  	 FW	I-NP
and  	and  	 CC	O
recurrences  	recurrences  	 NN	O
in  	in  	 IN	O
lymph  	lymph  	 JJ	O
nodes  	nodes  	 NN	O
may  	may  	 MD	O
be  	be  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
survival  	survival  	 NN	B-NP
benefit 	benefit 	 NN	I-NP
.  	.  	 .	O
